X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
index medicus (10) 10
adult (7) 7
female (7) 7
male (7) 7
oncology (7) 7
cancer (6) 6
middle aged (6) 6
hematology, oncology and palliative medicine (5) 5
stem cells (5) 5
adolescent (4) 4
chemotherapy (4) 4
leukemia, myeloid, acute - mortality (4) 4
stem-cell transplantation (4) 4
studies (4) 4
transplantation (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bone marrow (3) 3
health aspects (3) 3
hematopoietic stem cell transplantation (3) 3
leukemia (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - therapy (3) 3
medicine, general & internal (3) 3
prognosis (3) 3
therapy (3) 3
transplants & implants (3) 3
young adult (3) 3
abridged index medicus (2) 2
acute myeloid-leukemia (2) 2
age factors (2) 2
aged (2) 2
aged, 80 and over (2) 2
antigens (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
bone-marrow (2) 2
bone-marrow-transplantation (2) 2
care and treatment (2) 2
clinical trials (2) 2
consolidation (2) 2
cytarabine - therapeutic use (2) 2
elderly-patients (2) 2
fms-like tyrosine kinase 3 - genetics (2) 2
further section (2) 2
germany (2) 2
hematology (2) 2
internal medicine (2) 2
lymphocytes (2) 2
lymphocytes t (2) 2
medical prognosis (2) 2
medicine (2) 2
mortality (2) 2
multidisciplinary sciences (2) 2
paper (2) 2
patient outcomes (2) 2
protein kinase inhibitors - therapeutic use (2) 2
research (2) 2
research article (2) 2
risk factors (2) 2
science (2) 2
special section (2) 2
t cell receptors (2) 2
time factors (2) 2
transplantation, homologous (2) 2
treatment outcome (2) 2
1506 (1) 1
1720 (1) 1
1st remission (1) 1
3-iodobenzylguanidine (1) 1
3-weekly chop (1) 1
aberration (1) 1
ac133 antigen (1) 1
activation (1) 1
acute lymphatic leukemia (1) 1
acute lymphoblastic leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute lymphocytic leukemia (1) 1
acute myelogenous leukemia (1) 1
acute myeloid leukemia (1) 1
adoptive transfer (1) 1
adult palliative care (1) 1
adults (1) 1
advanced basic science (1) 1
amino acids (1) 1
aml (1) 1
analysis (1) 1
animal cells (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
anticancer properties (1) 1
antigenic determinants (1) 1
antigens, cd - metabolism (1) 1
antigens, cd34 - blood (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
anxieties (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9850, pp. 1309 - 1316
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1035 - 1044
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 12, pp. 1250 - 1259
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53190
Journal Article
Journal Article